Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Adv Exp Med Biol. 2020;1231:45-51. doi: 10.1007/978-3-030-36667-4_5.
Chemokines are soluble proteins that orchestrate cell migration in a regulated concentration gradient. During early stages of tumor development, chemokines shape the immune landscape of tumor microenvironment. CXCL9, also known as monokine induced by gamma-interferon (MIG), can be produced during inflammatory conditions by myeloid cells within the tumor microenvironment. It attracts cells expressing the CXCR3 receptor including activated T and NK cells and has been shown to play a role in responses to immune checkpoint therapy. Overexpression of CXCL9 has also shown to reduce tumor progression and metastasis via the inhibition of angiogenesis. Conversely, CXCL9 can act directly on tumor cells expressing the CXCR3 receptor to promote cell migration and epithelial mesenchymal transition. In this chapter we discuss the anti- and pro-tumoral features of CXCL9 within the tumor microenvironment.
趋化因子是可溶性蛋白,它们在受调控的浓度梯度中协调细胞迁移。在肿瘤发展的早期阶段,趋化因子塑造了肿瘤微环境中的免疫景观。CXCL9,也称为γ干扰素诱导的单核细胞趋化因子(MIG),可以在肿瘤微环境中的髓样细胞在炎症条件下产生。它吸引表达 CXCR3 受体的细胞,包括活化的 T 和 NK 细胞,并已被证明在免疫检查点治疗反应中发挥作用。CXCL9 的过表达也通过抑制血管生成来减少肿瘤的进展和转移。相反,CXCL9 可以直接作用于表达 CXCR3 受体的肿瘤细胞,促进细胞迁移和上皮间质转化。在本章中,我们讨论了 CXCL9 在肿瘤微环境中的抗瘤和促瘤特性。